Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2.
Bell JA, Davies ER, Brereton CJ, Vukmirovic M, Roberts JJW, Lunn K, Wickens L, Conforti F, Ridley RA, Ceccato J, Sayer LN, Johnston DA, Vallejo AF, Alzetani A, Jogai S, Marshall BG, Fabre A, Richeldi L, Monk PD, Skipp P, Kaminski N, Offer E, Wang Y, Davies DE, Jones MG. Bell JA, et al. Among authors: richeldi l. Cell Rep Med. 2024 Sep 17;5(9):101695. doi: 10.1016/j.xcrm.2024.101695. Epub 2024 Aug 21. Cell Rep Med. 2024. PMID: 39173635 Free PMC article.
Idiopathic pulmonary fibrosis: state of the art for 2023.
Podolanczuk AJ, Thomson CC, Remy-Jardin M, Richeldi L, Martinez FJ, Kolb M, Raghu G. Podolanczuk AJ, et al. Among authors: richeldi l. Eur Respir J. 2023 Apr 20;61(4):2200957. doi: 10.1183/13993003.00957-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36702498 Free article.
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
Behr J, Salisbury ML, Walsh SLF, Podolanczuk AJ, Hariri LP, Hunninghake GM, Kolb M, Ryerson CJ, Cottin V, Beasley MB, Corte T, Glanville AR, Adegunsoye A, Hogaboam C, Wuyts WA, Noth I, Oldham JM, Richeldi L, Raghu G, Wells AU. Behr J, et al. Among authors: richeldi l. Am J Respir Crit Care Med. 2024 Aug 15;210(4):392-400. doi: 10.1164/rccm.202401-0048PP. Am J Respir Crit Care Med. 2024. PMID: 38484133 No abstract available.
Peripheral Airway Sarcoidosis: Seeing What Was Previously Invisible.
Trisolini R, Pasciuto G, Cancellieri A, Agrosì C, Magnini D, Richeldi L. Trisolini R, et al. Among authors: richeldi l. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1328-1329. doi: 10.1164/rccm.202304-0781IM. Am J Respir Crit Care Med. 2023. PMID: 37642604 No abstract available.
Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib.
Mondoni M, Varone F, Alfano F, Muscato G, Conti C, Saderi L, Iovene B, Marco FD, Vancheri C, Richeldi L, Centanni S, Sotgiu G. Mondoni M, et al. Among authors: richeldi l. Arch Bronconeumol. 2023 Jul;59(7):464-466. doi: 10.1016/j.arbres.2023.02.010. Epub 2023 Feb 27. Arch Bronconeumol. 2023. PMID: 36894471 Free article. English, Spanish. No abstract available.
409 results